- Home
- CZFS vs EYPT Comparison
CZFS vs EYPT Comparison
Compare CZFS & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | EYPT |
|---|---|---|
| Founded | 1984 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.0M | 419.9M |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CZFS | EYPT |
|---|---|---|
| Price | $82.12 | $4.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $31.80 |
| AVG Volume (30 Days) | 30.7K | ★ 6.3M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 30.26 | N/A |
| EPS | ★ 4.28 | N/A |
| Revenue | ★ $9,881,000.00 | $7,539,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.64 | $3,115.57 |
| P/E Ratio | $19.30 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $52.35 | $3.95 |
| 52 Week High | $84.35 | $19.11 |
Technical Indicators
Market Signals| Indicator | CZFS | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 61.17 | 30.37 |
| Support Level | $78.38 | $3.95 |
| Resistance Level | $83.86 | $15.17 |
| Average True Range (ATR) | 2.44 | 0.58 |
| MACD | -0.36 | -0.16 |
| Stochastic Oscillator | 77.81 | 7.35 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.